Planet Labs Stock Skyrockets Ahead Of SpaceX's Friday IPO

Planet Labs shares rose 9.18% to $33.54 as traders rotated into public space-exposure names ahead of the expected $1.75 trillion SpaceX valuation. The move is being driven by sector sentiment and momentum rather than a company-specific catalyst, with AST SpaceMobile and Rocket Lab also seeing increased interest. Technically, PL remains below resistance at $37.00 and near support around $32.00, while MACD is still negative.

Analysis

The move looks less like a clean fundamentals re-rate in PL and more like a short-horizon liquidity event spilling over from the SpaceX valuation narrative. In that setup, the biggest winner is often the most accessible, highest-beta proxy with a credible “space data” story; public-market scarcity matters more than near-term revenue delta. That makes PL the current transmission vehicle, while ASTS and RKLB can participate as secondary momentum beneficiaries, and DXYZ/other private-markets wrappers may see a temporary bid as retail and smaller institutions hunt for quasi-SpaceX exposure.

The second-order effect is that this rally can compress near-term expectations for every listed space name, even those with very different economics. The risk is not just valuation; it is that capital rotates into the sector broadly and then quickly exits once the offering completes and the perceived scarcity premium fades. If PL cannot reclaim and hold the $37 area, this likely remains a trading tape rather than the start of a multi-week trend, especially given the weak momentum backdrop and the stock’s proximity to overhead supply.

Contrarian-wise, the market may be overestimating the durability of the “space basket” bid and underestimating how fast it can unwind. A higher-profile private-market transaction can temporarily lift adjacent equities, but it does not change execution risk, dilution risk, or the fact that many investors will treat listed names as substitutes rather than stand-alone theses. That means the best risk-adjusted expression is probably not outright long beta, but relative value: own the strongest operating stories and fade the weakest pure momentum names if the crowding becomes obvious.

Catalyst timing matters: the next 1-3 sessions are about flow and positioning, while the next 1-3 months will be about whether the group can hold gains without fresh headlines. A failure to clear resistance or a rotation out of speculative growth could quickly reverse 5-15% of the move. Conversely, if volume expands and PL stabilizes above near-term support, it can remain a preferred proxy for the sector until the IPO-related attention cycle passes.

Key Decisions for Investors

• Trade PL as a short-term momentum proxy only: buy on intraday/1-day pullbacks near $32-$33 with a tight stop below $32, targeting $37 over 1-3 weeks; reward/risk is roughly 2:1 if the sector bid persists.
• Use ASTS vs PL as a relative-value expression: long ASTS / short PL for 2-6 weeks if the market starts differentiating between higher-conviction operating optionality and crowded proxy exposure; this is a cleaner way to express a fade in the attention trade.
• Consider a tactical long RKLB vs short DXYZ basket if retail/private-markets enthusiasm spills over into wrapper vehicles; this captures the likelihood that public operating names retain more durable sponsorship than fund-of-SPV exposure.
• If PL loses $32 on a closing basis, fade the move with a short or put spread aiming for a retracement toward the high-$20s over 1-2 months; the setup is attractive because the catalyst is flow-driven, not a step-change in fundamentals.
• For options, prefer defined-risk call spreads in PL or ASTS rather than stock: 30-45 DTE bull call spreads capture the event-driven upside while limiting damage if the post-offering enthusiasm dissipates quickly.